Cleared Special

K233233 - EMPHASYS Femoral Stems (FDA 510(k) Clearance)

Oct 2023
Decision
13d
Days
Class 2
Risk

K233233 is an FDA 510(k) clearance for the EMPHASYS Femoral Stems. This device is classified as a Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (Class II - Special Controls, product code LZO).

Submitted by Depuy Ireland UC (Cork, IE). The FDA issued a Cleared decision on October 11, 2023, 13 days after receiving the submission on September 28, 2023.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3353.

Submission Details

510(k) Number K233233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2023
Decision Date October 11, 2023
Days to Decision 13 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code LZO — Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3353

Similar Devices — LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 41
Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem)
K253171 · Maxx Orthopedics, Inc. · Jan 2026
Coated hip implants
K250450 · Medacta International S.A. · Sep 2025
Longboard Revision Hip Stem
K243021 · Signature Orthopaedics Pty, Ltd. · Aug 2025
Z1 Hip System
K251906 · Zimmer, Inc. · Jul 2025
RECLAIM Monobloc Revision Femoral Stem
K251292 · Depuy Ireland UC · May 2025
MobileLink Acetabular Cup System - inhouse coatings
K243927 · Waldemar Link GmbH & Co. KG · May 2025